In this episode of "The Heart of Innovation," hosts Kym McNicholas and Dr. John Phillips delve into the groundbreaking advancements in limb salvage tools and techniques for patients with advanced stage peripheral artery disease, also known as Critical Limb Ischemia (CLI). Join us as we interview Howard Leonhardt, the Executive Chairman & CEO at Leonhardt Ventures LLC and Lionheart Health, a pioneering figure at the forefront of research and development in the field. Leonhardt sheds light on their team's innovative work in the development of bioelectrical stimulation signaling sequences, which have the remarkable ability to regulate the release of Klotho, a potent anti-aging and regeneration-promoting protein. If you are low in circulating Klotho you are aging more rapidly. Howard has patented a way to increase your circulating Klotho dramatically with bioelectric stimulation. Leonhardt Ventures is leading the charge as the world’s first Innovation Accelerator, with a focus on the convergence of bioelectrics & biologics for organ regeneration, longevity, wellness, and healing. Additionally, Lionheart Health is driving the commercialization of a full pipeline of Leonhardt patented inventions, targeting MedSpas and Sports Medicine Clinics, while also planning to establish numerous Lionheart Health Longevity and Wellness MedSpas over the next 5 years. Tune in to explore how this transformative technology platform featuring bioelectric stimulation controlled release of key anti-aging and health improvement proteins is poised to revolutionize not only limb salvage but also the broader landscape of longevity and wellness.